None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Adult men and women aged 18 to 80 - Patients who were found to be active in calculus formation - Calculus Index 2 or more on the lingual surface of the lower anterior teeth - Patients who can get proper brushing habits
Exclusion criteria
Exclusion criteria: - Pregnant or lactating women - Patients who have taken medicines that cause soft tissue enlargement within 2 weeks of screening (eg, diuretics, immunosuppressants, antagonists) or are probable to be taken during the trial - Patients with oral skin disease or lesions (eg, erosive lichen planus, erosive squamous cell carcinoma, oralitis, ulcer, malignant tumor) - Patients with moderate to severe periodontitis - Patients with systemic disease that have a significant effect on this trial - smokers more than 1/2 package daily - Patients with hypersensitivity to the same formulation (including ingredients) in the past - Patients who are judged to be inappropriate for the judgment of other clinicians
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical index: plaque index (PI), Gingival Index (GI), Calculus Index (CI), Probing Depth (PD), Bleeding on Probing (BOP), Gingival Recession and Clinical Attachment Level | — |
Secondary
| Measure | Time frame |
|---|---|
| microbiological analysis from saliva, gingivo-crevicular fluid, tooth surface swab | — |
Countries
Korea, Republic of
Contacts
Yonsei University